For the Quarter Ending December 2022
The Itraconazole market in the North American region fluctuated in the fourth quarter of 2022. Prices started to rise in Q4 2022 and kept growing due to high manufacturing costs, numerous logistical problems, and rising inflation through the second month of the fourth quarter.
Growing transportation costs and congestion at the key ports also helped maintain the market position. Furthermore, confusion and a slowdown in API output due to rising energy prices had a favorable effect on the market. Prices begin to decrease later in December as a result of falling inflation and decreasing end-user sector demand as the holiday season approaches. Towards the termination of Q4 2022, the prices of itraconazole API accessed at USD 366560/MT with an average quarterly inclination of 0.12%.
The Asia Pacific region experienced generally unchanged market sentiments for the itraconazole API during the fourth quarter of 2022. Due to strong demand from downstream pharmaceutical businesses, prices started to rise steadily at the beginning of the fourth quarter. Zero-covid policies and the installation of lockdowns both had an impact on the market environment. Later, as Q4 2022's second month got underway, lower production costs, sufficient stockpiles, and a strong supply caused the itraconazole API price trajectory to exhibit a stable trend. The domestic market was also sustained by steady end-user demand. Towards the termination of Q4 2022, the itraconazole API market prices were recoded as USD 345200/MT FOB Shanghai with an average quarterly inclination of 0.53%.
Itraconazole pricing in the European region exhibited a see-saw trend in the fourth quarter of 2022. The demand for itraconazole API in the pharmaceutical industry's downstream market was seen to be steady. In the first two months of Q4 2022, price increases were caused by the continuous port congestion and supply disruption in the European region. The trend of itraconazole was also impacted by increased freight costs. However, due to a decline in inflation, relief from port congestion, and a small amount of inventory held by domestic retailers, prices fell significantly in the month of December. Towards the termination of Q3 2022, the Itraconazole API market prices were recoded as USD 371820/MT CFR Hamburg with an average quarterly inclination of 0.12%.
For the Quarter Ending September 2022
In the North American region, Itraconazole API witnessed firm market sentiments in the third Quarter of 2022. Itraconazole API prices showcased a rising trend throughout the Quarter, owing to steady demand from downstream pharmaceutical industries. Furthermore, the price of raw material toluene also showcased an increasing trend globally with increasing energy values. With low operating rates and a supply crunch, the market experienced stable sentiments. Furthermore, the increased freight charge also affected the Itraconazole API market. Towards the termination of Q3 2022, the prices of Itraconazole API showed a rising trajectory with values accessed at USD 410580 /MT with an average quarterly inclination of 0.94%.
In the third Quarter of 2022, the Itraconazole API witnessed rising market sentiments in the Asia Pacific region. Throughout this Quarter, the prices increased gradually owing to firm demand from downstream pharmaceutical industries. Also, the hovering prices of Raw material toluene on the higher end affected the Itraconazole API market sentiments. Less production cost, enough inventories, and good supply prompted the Itraconazole API price trajectory to witness a stable trend. Stable demand from the end-user industry also stabilized the domestic market. Towards the termination of Q3 2022, the Itraconazole API market prices were recoded as USD 346850/MT FOB Shanghai with an average quarterly inclination of 1.16%.
In the third Quarter of 2022, the Itraconazole API in the European market was observed with stable market sentiments throughout the Quarter, taking cues from the ease in demand. Due to sinking demand from downstream pharmaceutical industries, the price was accessed to be firm. Also, enough inventories and low manufacturing costs kept the values at ease. The ease in the ongoing energy crisis in Europe prevailed its impact on the manufacturing facilities' operational loads. Towards the termination of Q3 2022, the Itraconazole API market prices were recoded as USD 375320/MT FOB Shanghai with an average quarterly inclination of 0.01%.